广州禾信仪器股份有限公司（以下简称"公司"）拟通过发行股份及支付现金的方式， 购买吴明、上海堰岛企业管理合伙企业（有限合伙）等两名交易对方合计持有的上海量羲 技术有限公司 56.00%股权并募集配套资金（以下简称"本次交易"）。 广州禾信仪器股份有限公司 关于延期回复《关于广州禾信仪器股份有限公司发行股份及支付现 金购买资产并募集配套资金暨关联交易申请的审核问询函》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 2025 年 8 月 27 日，公司收到上海证券交易所（以下简称"上交所"）出具的《关于 广州禾信仪器股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易申 请的审核问询函》（上证科审（并购重组）〔2025〕30 号）（以下简称"《审核问询函》"）。 根据《审核问询函》的要求，公司回复审核问询的时间总计不得超过 1 个月，如难以在前 述时间内回复的，可以按照《上海证券交易所上市公司重大资产重组审核规则》的规定， 向上交所申请延期一次，时间不得超过 1 个月。 证券代码：688622 证券简称：禾信仪器 ...

通信行业点评 姚院士在浦江论坛对量子提出了怎样的期待？ 2025 年 09 月 23 日 ➢ 2025 年 9 月 21 日浦江创新论坛上，姚院士就量子计算+A 开展演讲，认 为两者可"相互赋能"。"将量子与 AI 这两项颠覆性技术结合，或许能推动人类 突破现有知识极限，实现系统能力的跃升。"在姚期智院士看来，二者的融合不是 简单叠加，而是相互赋能的"化学反应"。大会同时宣布成立上海量子人工智能联 合体、上海量子科技装备产业创新联盟，发布上海量子计算十大应用场景，标志 上海量子科技与产业发展迈入崭新发展阶段。 ➢ 我国 AI 量子：基础扎实潜力无限。大会上指出，当前我国在量子纠错、AI 赋能量子等领域紧跟国际前沿，最新研究进展在部分方向上已经具备了"并跑"， 甚至局部"领跑"的可能。中国科学院院士俞大鹏指出，中国在量子计算领域已 取得显著突破。在上海，复旦大学成功研制出中性原子量子计算系统，制定高效 并行量子计算指令集；开发 ai+量子调控方案，实现了大规模原子系统的自动校 准、优化，为量子计算增效提速；自研物镜的性能也已支撑万比特级中性原子量 子计算；近期在量子优化算法上又取得新突破，大幅提升 NP 难问题 ...

Group 1 - The core point of the announcement is the successful holding of the second extraordinary general meeting of shareholders for Guangzhou Hexin Instrument Co., Ltd., where a resolution regarding the change of registered capital and the amendment of the company's articles of association was passed [1][3]. - The meeting was convened by the board of directors and chaired by Chairman Zhou Zhen, utilizing a combination of on-site and online voting methods, in compliance with the Company Law and the company's articles of association [2][3]. - All nine current directors attended the meeting, along with the board secretary and other senior management personnel, ensuring a full representation of the company's leadership [3]. Group 2 - The resolution regarding the change of registered capital was a special resolution that received approval from more than two-thirds of the valid voting rights held by shareholders and their proxies present at the meeting [3]. - There were no rejected proposals during the meeting, indicating a unanimous agreement on the discussed agenda [2][4]. - The meeting was legally witnessed by Beijing Zhonglun (Guangzhou) Law Firm, confirming that the convening and voting procedures adhered to legal and regulatory requirements [5][6].

证券代码：688622 证券简称：禾信仪器 公告编号：2025-058 重要内容提示： 本次会议是否有被否决议案：无 一、会议召开和出席情况 （一）股东会召开的时间：2025 年 9 月 17 日 （二）股东会召开的地点：广州市黄埔区新瑞路 16 号 1 楼公司大会议室 （三）出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及其 持有表决权数量的情况： 广州禾信仪器股份有限公司 2025年第二次临时股东会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 | 1、出席会议的股东和代理人人数 | 31 | | --- | --- | | 普通股股东人数 | 31 | | 2、出席会议的股东所持有的表决权数量 | 29,997,779 | | 普通股股东所持有表决权数量 | 29,997,779 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 42.5708 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 42.5708 | （四）表决方式是否符合《 ...

北京市中伦（广州）律师事务所 关于广州禾信仪器股份有限公司 2025 年第二次临时股东会的 法律意见书 二〇二五年九月 本所及本所律师依据《中华人民共和国证券法》（以下简称"《证券法》"）、 《律师事务所从事证券法律业务管理办法》和《律师事务所证券法律业务执业规 则（试行）》等规定及本法律意见书出具日以前已经发生或者存在的事实，严格 履行了法定职责，遵循了勤勉尽责和诚实信用原则，进行了充分的核查验证，保 证本法律意见所认定的事实真实、准确、完整，所发表的结论性意见合法、准确， 不存在虚假记载、误导性陈述或者重大遗漏，并承担相应法律责任。 北京市中伦（广州）律师事务所 关于广州禾信仪器股份有限公司 2025 年第二次临时股东会的 本法律意见书根据《中华人民共和国公司法》（以下简称"《公司法》"）、《证 券法》等现行有效的法律、法规、规范性文件以及《广州禾信仪器股份有限公司 章程》（以下简称"《公司章程》"）、《广州禾信仪器股份有限公司股东会议事规则》 （以下简称"《股东会议事规则》"）的规定而出具。 法律意见书 致：广州禾信仪器股份有限公司 北京市中伦（广州）律师事务所（以下简称"本所"）接受广州禾信仪器股 份 ...

Group 1 - The company, Guangzhou Hexin Instrument Co., Ltd., will participate in the "2025 Guangdong Investor Online Collective Reception Day" to enhance interaction with investors [1] - The event will be held online on September 19, 2025, from 15:30 to 17:00, allowing investors to engage through the "Panorama Roadshow" website [1] - Key company executives, including the Chairman and General Manager, will discuss the company's 2025 semi-annual performance, governance, development strategy, operational status, financing plans, equity incentives, and sustainable development [1]

特此公告。 为进一步加强与投资者的互动交流，广州禾信仪器股份有限公司 （以下简称"公司"）将参加由中国证券监督管理委员会广东监管局、 广东上市公司协会联合举办的"向新提质 价值领航--2025 年广东辖 区投资者集体接待日暨辖区上市公司中报业绩说明会"，现将相关事 项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演" 网站（http://rs.p5w.net）参与本次互动交流，活动时间为 2025 年 9 月 19 日（周五）15:30-17:00。届时公司董事长兼总经理周振先生、 董事兼董事会秘书陆万里先生、财务总监孙建德先生与独立董事陈明 先生将以网络文字互动方式就公司 2025 年半年度业绩、公司治理、 发展战略、经营状况、融资计划、股权激励和可持续发展等投资者关 心的问题，与投资者进行沟通与交流，欢迎广大投资者踊跃参与！ 证券代码：688622 证券简称：禾信仪器 公告编号：2025-057 广州禾信仪器股份有限公司 关于参加 2025 年广东辖区投资者 网上集体接待日活动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、 ...

Group 1 - Quantum technology concept showed strong fluctuations during trading, with Guodun Quantum rising over 10% [1] - Other companies such as Keda Guokai, Hexin Instruments, Shenzhou Information, and Fudan Fuhua also experienced gains [1] - Guodun Quantum announced on the evening of September 12 that the company and its subsidiaries plan to sign a sales contract for quantum terminal equipment and a 280+ bit superconducting quantum computing project with China Telecom Quantum Group, with an expected amount of 63.054 million yuan [1]

Summary of the Conference Call on the Scientific Instrument Industry Industry Overview - The scientific instrument industry in China is experiencing growth driven by increasing R&D expenditure, which reached 3.34 trillion yuan in 2023, a year-on-year increase of 8.4% [1][3] - The market for scientific instruments, including mass spectrometry, chromatography, and spectroscopy, exceeds 50 billion yuan, but remains highly dependent on imports, with mass spectrometry and chromatography import rates at 90% and 88% respectively [1][3] Key Insights - The proportion of R&D expenditure to GDP in China has been steadily increasing, reaching 2.6% in 2023, indicating stronger governmental support for technological innovation and a rising demand for high-end scientific instruments [1][3][6] - The mass spectrometry market in China is approaching 20 billion yuan, with a growth rate of approximately 15%, but it is still heavily reliant on imports, particularly from the U.S., which maintains a stable market share of around 20% [1][8][10] - The scientific service industry encompasses research institutions, universities, and innovative enterprises, providing high-tech solutions and third-party testing services, characterized by high technological content and talent concentration [4][5] Market Dynamics - The scientific instrument supply chain consists of three main segments: 1. Reagent and consumables companies (e.g., Titan Technology, Aladdin) 2. Scientific instrument manufacturers (e.g., Focused Photonics, Labtech) 3. Third-party testing service providers (e.g., Huace Testing, Puni Testing) [6] - The increasing focus on domestic scientific instruments due to U.S.-China trade tensions is expected to enhance the market share of domestic manufacturers [3][10] Competitive Landscape - There is a significant gap between Chinese scientific service companies and their overseas counterparts, with leading foreign firms like Merck and Agilent having market capitalizations exceeding 100 billion USD, while only five Chinese companies exceed 10 billion USD in market cap [2][11] - The average gross margin for Chinese companies is 46%, lower than the 52% average for foreign companies, indicating potential for profit margin improvement as domestic companies scale up [11][12] Future Outlook - As penetration rates increase and costs decrease, the gross margins of Chinese scientific service companies are expected to improve, potentially leading to the emergence of new domestic leaders in the industry [12] - Investment recommendations include focusing on companies engaged in R&D and the scientific instrument sector, such as Focused Photonics, Wuyi Technology, and Labtech, which are in the early stages but show significant growth potential [13]

Core Insights - The precision instrument industry in China is in a stage of technological catch-up, experiencing rapid growth driven by policy support and market demand [1][9] - The market size of China's precision instrument industry is projected to reach 898.8 billion yuan in 2024 and approximately 960 billion yuan in 2025 [1][10] - The industry is becoming a core engine for driving strategic emerging industries such as intelligent manufacturing, biomedicine, and new energy [1][10] Industry Definition and Characteristics - Precision instruments are complex devices that integrate mechanical, electronic, optical, and computer technologies, characterized by high precision, high sensitivity, and high reliability [1][2] Industry Development Environment - Related Policies - The Chinese government has increased its focus on the precision instrument sector, implementing several policies to support its development, including the "14th Five-Year Plan" for the mechanical industry and guidelines for high-quality development of the measurement and instrumentation industry [4] Current State of the Precision Instrument Industry - The global precision instrument industry is strategically supported by various countries, with the U.S. maintaining a leading position, followed by Germany and Japan [5][7] - China's precision instrument industry has seen significant growth in financing, with the number of financing events increasing from 9 in 2014 to 80 in 2024 [9][10] Industry Value Chain - The upstream of the precision instrument industry includes components like sensors and detectors, while the midstream focuses on design, research, and manufacturing [12] Competitive Landscape - The precision instrument industry is characterized by a competitive landscape dominated by international giants, with local companies like East Mountain Precision and Tianrui Instruments rapidly emerging [13] Industry Development Trends - The precision instrument sector is evolving towards extreme, intelligent, integrated, rapid, refined, and networked trends, with increasing demands for measurement accuracy and manufacturing precision [14]